Back to results
TerminatedPhase 2

Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer

NCT00542191

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Brody School of Medicine at East Carolina University

Greenville, North Carolina, United States

View on ClinicalTrials.gov
Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer — TrialFind